A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...
FluMist, the nasal flu vaccine spray, was approved in September by the U.S. Food and Drug Administration for at-home use ...
BOSTON — A new study found a new drug-free nasal spray may protect against respiratory infections like COVID and the flu, ...
Miacalcin is fairly easy to take - a dose is one spray in one nostril per day (switch nostrils each ... Miacalcin can cause soreness on the inside of the nose (the nasal passages).
In April, she’d begun to use a topical nasal-spray decongestant. The over-the-counter (OTC) drug worked like a charm. By summer, she was still using the spray daily. Yet it was helping for ...
Mometasone (as furoate monohydrate) 50mcg/spray. Mometasone is a corticosteroid ... symptoms in patients ≥2yrs of age. Prophylaxis of nasal symptoms of seasonal allergic rhinitis symptoms ...
The FDA has approved a new flu vaccine nasal spray for at-home use. While this self-administered version won't be available for this year's flu season, interest in nasal spray products is growing.
Give as single spray intranasally into one nostril. May give additional doses (using a new nasal spray) every 2–3mins in alternate nostrils if unresponsive or relapses into respiratory depression.
Vaccines delivered through a spray into the nose could offer better protection and fewer side effects than traditional vaccine shots in the arm.
Researchers found that a drug-free nasal spray protected against airborne respiratory illnesses — including Covid-19, influenza, viruses, and pneumonia — in a preclinical study published by ...
An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...
Those struggles would end, however, if all her future vaccinations could be delivered by a nasal spray. “Oh, my God, amazing!” Velasquez says. If you're enjoying this article, consider ...